Overview

The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel Resistance

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Continuing high dose clopidogrel treatment after elective PCI decreased adverse cardiac events in patients with clopidogrel resistance
Phase:
Phase 3
Details
Lead Sponsor:
Bursa Postgraduate Hospital
Treatments:
Clopidogrel
Ticlopidine